Skip to ContentSkip to Navigation
Research Medical Microbiology
University Medical Center Groningen

PhD ceremony Mr. H.P. Patil: Development of adjuvanted influenza vaccines for pulmonary delivery

Development of adjuvanted influenza vaccines for pulmonary delivery
17 February 2014

PhD ceremony: Mr. H.P. Patil, 12.45 uur, Academiegebouw, Broerstraat 5, Groningen

Dissertation: Development of adjuvanted influenza vaccines for pulmonary delivery

Promotor(s): prof. A.L.W. Huckriede, prof. J.C. Wilschut

Faculty: Medical Sciences

Summary:

Influenza virus is well known for its ability to cause seasonal epidemics and occasional pandemics, both with very large impact on society. Vaccination has proven to be effective in controlling influenza epidemics and pandemics but current vaccines are still suboptimal: they have to be administered by tedious intramuscular injection; are highly vulnerable to degradation when not stored within a very tight temperature range (2-8°C), and they fail to elicit immunity in the nose and throat and thus to prevent early stages of the infection.

To overcome these drawbacks we converted liquid vaccine to a dry powder and delivered this powder vaccine directly to the lungs (pulmonary immunization). Dry powder vaccines produced with suitable sugars as stabilizer were stable at temperatures of 30°C for at least 3 months. Two administrations of these powder vaccines to the lungs elicited influenza specific immunity comparable to that achieved by conventional intramuscular injection. The immune responses could be further improved and the local immunity in the airways could be stimulated by including suitable immune-stimulating agents, so-called adjuvants, in the vaccine.

The findings in this thesis indicate that the production of stable influenza vaccines is feasible and that such vaccines elicit strong local and systemic immunity when administered to the lungs e.g. by simple inhalation. The stability of the vaccine and the ease of administration makes dry powder vaccines especially suitable for use in resource-poor countries and for mass vaccination campaigns as required in case of pandemics.

Last modified:09 May 2019 11.27 a.m.
View this page in: Nederlands

More news

  • 24 May 2024

    Lustrum 410 in pictures

    Lustrum 410 in pictures: We are already over half way through our lustrum! Enjoy a few photos of the lustrum so far.

  • 21 May 2024

    Results of 2024 University elections

    The votes have been counted and the results of the University elections are in!

  • 13 May 2024

    Trapping molecules

    In his laboratory, physicist Steven Hoekstra is building an experimental set-up made of two parts: one that produces barium fluoride molecules, and a second part that traps the molecules and brings them to an almost complete standstill so they can...